Schedule 13D ownership disclosure

Entrada Therapeutics Inc

Security class unavailable · CUSIP: 29384C108

Event date: 2024-06-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,865,819
Percent of class
13.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-075206
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Jun 26, 2024
Reporting period
Jun 24, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub